Welcome

You are being redirected to a version of this site intended for users in the United Kingdom.

Accept

Close and Stay on US Site

Understanding treatment with antibody-drug conjugates (ADCs)

Science keeps opening doors for metastatic breast cancer treatment options. One targeted approach is a class of medications called antibody-drug conjugates, also known as ADCs.

What are ADCs? Life on an ADC Common questions about ADCs
What are ADCs?
Life on an ADC
Common questions about ADCs
video thumbnail
play button icon

What are ADCs?

Antibody-drug conjugates, or ADCs, are a type of targeted cancer treatment designed to deliver medicines more directly to cancer cells. Learn how this targeted medicine works and why it may be an option for some people with MBC.

Life on an
ADC

For Janet and Vanessa, a metastatic triple-negative breast cancer (TNBC) diagnosis brought new challenges. In these conversations, they'll confront uncertainty, share their experiences on an ADC and navigate the realities of living with advanced cancer.

play button icon

Episode 1: Before ADC Treatment

play button icon

Episode 2: Side Effects & Community

play button icon

Episode 3: Enduring Joy & Faith

Common questions about ADCs

Who are antibody-drug conjugates for? How are they different from traditional chemotherapy? Janet and Vanessa's breast oncologist, Dr. Gregory Vidal from West Cancer Center and Research Institute, shares the basics about ADCs.

video thumbnail
play button icon

Making informed decisions about your treatment options begins with a trusted relationship with your oncologist.

  • What are ADCs?

    Antibody-drug conjugates, or ADCs, are a type of targeted cancer treatment designed to deliver medicines more directly to cancer cells, while limiting the impact on healthy cells. This means a more focused approach to killing those cancer cells, possibly delivering higher concentrations of the anticancer medicine closer to the area it's supposed to go.

  • What is the difference between an ADC and traditional chemotherapy?

    Traditional chemotherapy travels everywhere in your bloodstream, killing cancer cells while also potentially damaging healthy cells. ADCs are a targeted medicine, meaning they aim to deliver treatment more directly to the cancer cells and limit the impact on healthy cells.

  • How should you discuss side effects, and how to manage them, with your doctor?

    ADCs for MBC, including mTNBC, have side effects that can vary by the treatment you receive. It's important to immediately and openly share any symptoms you experience with your care team, as they may help manage these effects.

  • When might an ADC be a treatment option?

    ADCs may be used for certain patients with metastatic breast cancer, which is cancer that has spread to other parts of the body. Some patients may now be able to receive ADCs earlier in their treatment journey. Please reach out to your healthcare provider for any questions or information about your condition. Treatment options and results will vary, and your experiences may be different.

Need more support?

Cancer can be a long and difficult journey for all those affected. Regardless of the stage or severity of the cancer, or how far into treatment you are, as a patient or caregiver, finding the support you need as an individual is important. There are many resources available to help you find the support you need.